CoChat

Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease

Open access

The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Alzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk. METHODS: We performed a genome-wide screen of DNA methylation using the Illumina Infinium HumanMethylation450 platform on bulk tissue samples from the superior temporal gyrus of patients with Alzheimer's disease and non-demented controls. We paired a sliding window approach with multivariate linear regression to characterize Alzheimer's disease-associated differentially methylated regions (DMRs). RESULTS: We identified 479 DMRs exhibiting a strong bias for hypermethylated changes, a subset of which were independently associated with aging. DMR intervals overlapped 475 RefSeq genes enriched for gene ontology categories with relevant roles in neuron function and development, as well as cellular metabolism, and included genes reported in Alzheimer's disease genome-wide and epigenome-wide association studies. DMRs were enriched for brain-specific histone signatures and for binding motifs of transcription factors with roles in the brain and Alzheimer's disease pathology. Notably, hypermethylated DMRs preferentially overlapped poised promoter regions, marked by H3K27me3 and H3K4me3, previously shown to co-localize with aging-associated hypermethylation. Finally, the integration of DMR-associated single nucleotide polymorphisms with Alzheimer's disease genome-wide association study risk loci and brain expression quantitative trait loci highlights multiple potential DMRs of interest for further functional analysis. CONCLUSION: We have characterized changes in DNA methylation in the superior temporal gyrus of patients with Alzheimer's disease, highlighting novel loci that facilitate better characterization of pathways and mechanisms underlying Alzheimer's disease pathogenesis, and improve our understanding of epigenetic signatures that may contribute to the development of disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-015-0258-8

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Genome-wide distribution and characteristics of differentially methylated regions identified in the superior temporal gyrus of patients with Alzheimer’s disease (AD). a Manhattan plot showing -log10 P-values from the sliding-window analysis of autosomal CpGs in AD cases versus controls. b Comparison of population level mean β-values for hypomethylated (blue, n = 1,260) and hypermethylated (red, n = 3,395) CpGs, and background CpGs (black; all autosomal CpGs screened, n = 461,272). c Distribution of per CpG mean β-value changes associated with AD status (>0, red; <0, blue) estimated by multiple regression, after regressing out effects of age, gender, race, and neuronal/glial cell proportions. Only data for CpGs within DMRs that were independently significant by linear regression (P < 0.05; n = 2,220) are plotted
Fig. 1 Genome-wide distribution and characteristics of differentially methylated regions identified in the superior temporal gyrus of patients with Alzheimer’s disease (AD). a Manhattan plot showing -log10 P-values from the sliding-window analysis of autosomal CpGs in AD cases versus controls. b Comparison of population level mean β-values for hypomethylated (blue, n = 1,260) and hypermethylated (red, n = 3,395) CpGs, and background CpGs (black; all autosomal CpGs screened, n = 461,272). c Distribution of per CpG mean β-value changes associated with AD status (>0, red; <0, blue) estimated by multiple regression, after regressing out effects of age, gender, race, and neuronal/glial cell proportions. Only data for CpGs within DMRs that were independently significant by linear regression (P < 0.05; n = 2,220) are plottedCC BY · PubMed Central
Fig. 2 Neighboring CpGs within significant differentially methylated regions (DMRs) exhibit consistent between-group differences in DNA methylation. Zoomed -log10 P-value plots for chromosome 22 (a, upper panel) and chromosome 19 (b, upper panel). The positions of significant DMRs corresponding to plotted green points in (a) and (b) are shown in the context of RefSeq gene annotations (hg18) for promoter regions of MOV10L1 (a, middle panel) and KLK7 (b, middle panel). The approximate positions of each DMR are indicated by red shaded boxes. Detailed images for each locus (lower panels) showing individual CpG β-values, with Alzheimer’s disease (AD) samples shown in blue and control samples in gray. The AD and control group mean β-values are indicated by solid blue and gray lines, respectively. Mb megabase
Fig. 2 Neighboring CpGs within significant differentially methylated regions (DMRs) exhibit consistent between-group differences in DNA methylation. Zoomed -log10 P-value plots for chromosome 22 (a, upper panel) and chromosome 19 (b, upper panel). The positions of significant DMRs corresponding to plotted green points in (a) and (b) are shown in the context of RefSeq gene annotations (hg18) for promoter regions of MOV10L1 (a, middle panel) and KLK7 (b, middle panel). The approximate positions of each DMR are indicated by red shaded boxes. Detailed images for each locus (lower panels) showing individual CpG β-values, with Alzheimer’s disease (AD) samples shown in blue and control samples in gray. The AD and control group mean β-values are indicated by solid blue and gray lines, respectively. Mb megabaseCC BY · PubMed Central
Fig. 3 Summary characteristics of differentially methylated region (DMR) CpGs in the context of gene and CpG island features. Proportion of CpGs within hypermethylated DMRs, hypomethylated DMRs, and background CpG sets that fall within various gene (a) and CpG island (b) feature annotations
Fig. 3 Summary characteristics of differentially methylated region (DMR) CpGs in the context of gene and CpG island features. Proportion of CpGs within hypermethylated DMRs, hypomethylated DMRs, and background CpG sets that fall within various gene (a) and CpG island (b) feature annotationsCC BY · PubMed Central
Fig. 4 Differentially methylated genes (DMRs) are enriched in genes and functional genomic regions with relevance to Alzheimer’s disease pathology. a Summary of gene ontology (GO) term enrichments for DMR-associated genes (n = 475). Significantly enriched terms (q < 0.2) are ranked by estimated fold-enrichment, and colored according to their broader classification (“Molecular Function,” “Biological Process,” and “Cellular Component”). The number of DMR-associated genes (min = 6; max = 268) categorized in each GO term are indicated by circle size. b Heat map of raw P-values associated with enrichment analysis DMRs in regions characterized by individual and combined histone signatures in adult and fetal brain/neuron datasets. Red boxes indicate significant enrichments after correction (corrected P < 0.05). c Significant enrichments of transcription factor binding site motifs within DMR-associated RefSeq gene promoters, based on analysis of datasets curated separately in a medulloblastoma cell line (upper panel) and a lymphoblastoid cell line (lower panel). Motifs are labeled along the x-axis, and are shown in ranked order in each panel according to fold-enrichment. Bonferroni-corrected -log10 P-values are shown as asterisks
Fig. 4 Differentially methylated genes (DMRs) are enriched in genes and functional genomic regions with relevance to Alzheimer’s disease pathology. a Summary of gene ontology (GO) term enrichments for DMR-associated genes (n = 475). Significantly enriched terms (q < 0.2) are ranked by estimated fold-enrichment, and colored according to their broader classification (“Molecular Function,” “Biological Process,” and “Cellular Component”). The number of DMR-associated genes (min = 6; max = 268) categorized in each GO term are indicated by circle size. b Heat map of raw P-values associated with enrichment analysis DMRs in regions characterized by individual and combined histone signatures in adult and fetal brain/neuron datasets. Red boxes indicate significant enrichments after correction (corrected P < 0.05). c Significant enrichments of transcription factor binding site motifs within DMR-associated RefSeq gene promoters, based on analysis of datasets curated separately in a medulloblastoma cell line (upper panel) and a lymphoblastoid cell line (lower panel). Motifs are labeled along the x-axis, and are shown in ranked order in each panel according to fold-enrichment. Bonferroni-corrected -log10 P-values are shown as asterisksCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 111 references

Cited by

See all 203

Metadata

Authors
Watson, C. T., Roussos, P., Garg, P., Ho, D. J., Azam, N., Katsel, P. L., Haroutunian, V., & Sharp, A. J.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • New York/New Jersey VA Health Care Network (US)
Corresponding author
Sharp, Andrew J.
Venue
Genome Medicine
Published
2016-01-19
Volume
8
Issue
1
Pages
5-5
ISSN
1756-994X (ISSN-L)
OpenAlex
W2279197036
Cited by
201
References
112
Citations by year
2026: 7 · 2025: 17 · 2024: 15 · 2023: 18 · 2022: 23 · 2021: 24 · 2020: 22 · 2019: 25 · 2018: 20 · 2017: 24 · 2016: 5
FWCI
12.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Alzheimer's Association (2012ALZNIRG69983)
  • National Institutes of Health (DA033660, HG006696, HD073731, MH097018, AG05138)
  • March of Dimes Foundation (6-FY13-92)
  • U.S. Department of Health and Human Services (HHSN271291300031)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, DNA methylation, superior temporal gyrus, differentially methylated regions, epigenetic signatures, brain aging, H3K27me3, H3K4me3, transcription factor binding motifs, single nucleotide polymorphisms, expression quantitative trait loci, neurodegeneration
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Humans, Temporal Lobe, DNA Methylation, Epigenesis, Genetic, Gene Regulatory Networks, Genome-Wide Association Study, Gene Ontology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease. https://app.cochat.ai/papers/10.1186/s13073-015-0258-8
The paper
Watson, C. T., Roussos, P., Garg, P., Ho, D. J., Azam, N., Katsel, P. L., Haroutunian, V., & Sharp, A. J. (2016). Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease. Genome Medicine. https://doi.org/10.1186/s13073-015-0258-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.